RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for an expanded indication to treat adult and pediatric Urology patients with the Senhance® Surgical System. "This FDA clearance marks another milestone for Asensus Surgical and represents an additional indication expansion in the U.S. ...

RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for an expanded indication to treat adult and pediatric Urology patients with the Senhance® Surgical System. “This FDA clearance marks another milestone for Asensus Surgical and represents an additional indication expansion i ...

RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement to lease and utilize a Senhance® Surgical System. LKH-Universitätsklinikum Graz is a renowned healthcare institution known for its expertise in minimally invasive pediatric and adolescent surgery. This hospital will be the 7t ...

Asensus Surgical, Inc. (ASXC) announced an agreement with St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan on leasing its Senhance Surgical System. The hospital will use the system in its Urology and Gastroenterology/General Surgery department. The Senhance Surgical System can effortlessly integrate human skills with clinical intelligence. Asensus Surgical's latest deal on this system underscores the hospital's dedication to medical innovation.More on the NewsThe Senhance Sur ...

Asensus Surgical Inc. (ASXC) gets into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., a wholly owned subsidiary of KARL STORZ SE & Co. KG. The merger agreement states that KARL STORZ will acquire all of the outstanding shares of Asensus Surgical for 35 cents per share in cash.The merger is expected to maximize Asensus Surgical’s stockholder value. With this transaction, Asensus will have a greater opportunity to advance in safer, predictable surgery and digital tools for patients and ...

NEW YORK, June 7, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Asensus Surgical, Inc. (NYSE: ASXC), relating to its proposed merger with KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ SE & Co. KG. Under the terms of the ...

MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Asensus Surgical (NYSE: ASXC) for possible breaches of fiduciary duty and other violations of law in its transaction with KARL STORZClick here to learn how to join the investigation: https://www.ademilaw.com/case/asensus-surgical-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.In the transaction, Asensus Surgical shareholders will receive only $0.35 per share in cash. The transaction agreement unreaso ...

KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC) ("Asensus Surgical" or "Asensus"), a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger agreement (the "Merger Agreement") with KARL STORZ Endoscopy-America, Inc. ("KARL STORZ"), a wholly owned direct subsidiary ...

KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus Surgical” or “Asensus”), a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. ("KARL STORZ"), a wholly owned direct ...